Old Web
English
Sign In
Acemap
>
authorDetail
>
Patrice Belanger
Patrice Belanger
Pfizer
Internal medicine
Endocrinology
Tanezumab
Nerve growth factor
Chronic pain
4
Papers
33
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Effects of tanezumab on satellite glial cells in the cervicothoracic ganglion of cynomolgus monkeys: A 26-week toxicity study followed by an 8-week recovery period
2019
Autonomic Neuroscience: Basic and Clinical
Mark G. Evans
Mark Butt
Patrice Belanger
Thomas Cummings
Jessica-lyn Gremminger
Mark Zorbas
Show All
Source
Cite
Save
Citations (1)
Development of pain therapies targeting nerve growth factor signal transduction and the strategies used to resolve safety issues
2018
Journal of Toxicological Sciences
Patrice Belanger
Christine R. West
Mark T. Brown
Show All
Source
Cite
Save
Citations (12)
From the Cover: Evaluation of the Effects of Tanezumab, a Monoclonal Antibody Against Nerve Growth Factor, on the Sympathetic Nervous System in Adult Cynomolgus Monkeys (Macaca fascicularis): A Stereologic, Histomorphologic, and Cardiofunctional Assessment
2017
Toxicological Sciences
Patrice Belanger
Paul Butler
Mark Butt
Siddhartha Bhatt
Stephen Foote
David L. Shelton
Mark G. Evans
Rosalinda Arends
Susan Hurst
Carlin Okerberg
Thomas Cummings
David M. Potter
Jill Steidl-Nichols
Mark Zorbas
Show All
Source
Cite
Save
Citations (20)
Scientific strategies necessary to resolve FDA clinical hold on anti-nerve growth factor inhibitors: The story of tanezumab
2016
Journal of Toxicological Sciences
Patrice Belanger
Mark Butt
Paul Butler
Siddhartha Bhatt
Stephen Foote
Dave Shelton
Mark G. Evans
Rosalin Arends
Susan Hurst
Carlin Okerberg
Thomas Cummings
David M. Potter
Jill Steidl-Nichols
Mark Zorbas
Show All
Source
Cite
Save
Citations (0)
1